ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Solvonis Therapeutics Plc

Solvonis Therapeutics Plc (SVNS)

0.185
0.0025
(1.37%)
Closed 02 February 3:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.185
Bid
0.18
Offer
0.19
Volume
5,736,324
0.1825 Day's Range 0.19
0.155 52 Week Range 0.235
Market Cap
Previous Close
0.1825
Open
0.1825
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
22,655,254
Shares Outstanding
2,295,930,633
Dividend Yield
-
PE Ratio
-1.14
Earnings Per Share (EPS)
-0
Revenue
587k
Net Profit
-3.12M

About Solvonis Therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
London, Gbr
Founded
-
Solvonis Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker SVNS. The last closing price for Solvonis Therapeutics was 0.18p. Over the last year, Solvonis Therapeutics shares have traded in a share price range of 0.155p to 0.235p.

Solvonis Therapeutics currently has 2,295,930,633 shares in issue. The market capitalisation of Solvonis Therapeutics is £4.19 million. Solvonis Therapeutics has a price to earnings ratio (PE ratio) of -1.14.

SVNS Latest News

Solvonis Therapeutics PLC Proactive Investors interview with Chairman

Solvonis Therapeutics PLC 30 January 2025   RNS Reach - non-regulatory announcement 30 January 2025 Solvonis Therapeutics plc ("Solvonis Therapeutics" or the "Company")   Proactive Investors...

Solvonis Therapeutics PLC Update on Awakn Life Sciences’ R&D Progress

Solvonis Therapeutics PLC 27 January 2025   27 January 2025   Solvonis Therapeutics plc ("Solvonis" or the "Company") Update on Awakn Life Sciences' Research and Development Progress  ...

Solvonis Therapeutics PLC Investor Presentation

Solvonis Therapeutics PLC 24 January 2025   REACH: non-regulatory announcement 24 January 2025   SOLVONIS THERAPEAUTICS PLC ("Solvonis" or the "Company")   Investor Presentation   Solvonis...

Solvonis Therapeutics PLC Proactive Investors interview with CEO

Solvonis Therapeutics PLC 21 January 2025   RNS Reach - non-regulatory announcement 21 January 2025 Solvonis Therapeutics plc ("Solvonis Therapeutics" or the "Company")   Proactive Investors...

Solvonis Therapeutics PLC Update on FDA Pre-IND Meeting for Awakn

Solvonis Therapeutics PLC 21 January 2025   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED...

Solvonis Therapeutics PLC Interview with CEO

Solvonis Therapeutics PLC 15 January 2025   RNS Reach - non-regulatory announcement 15 January 2025 Solvonis Therapeutics plc ("Solvonis Therapeutics" or the "Company")   Proactive Investors...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0052.777777777780.180.190.1894131560.18614501DE
40.0212.12121212120.1650.2350.155226552540.19662558DE
120.0212.12121212120.1650.2350.155226552540.19662558DE
260.0212.12121212120.1650.2350.155226552540.19662558DE
520.0212.12121212120.1650.2350.155226552540.19662558DE
1560.0212.12121212120.1650.2350.155226552540.19662558DE
2600.0212.12121212120.1650.2350.155226552540.19662558DE

SVNS - Frequently Asked Questions (FAQ)

What is the current Solvonis Therapeutics share price?
The current share price of Solvonis Therapeutics is 0.185p
How many Solvonis Therapeutics shares are in issue?
Solvonis Therapeutics has 2,295,930,633 shares in issue
What is the market cap of Solvonis Therapeutics?
The market capitalisation of Solvonis Therapeutics is GBP 4.19M
What is the 1 year trading range for Solvonis Therapeutics share price?
Solvonis Therapeutics has traded in the range of 0.155p to 0.235p during the past year
What is the PE ratio of Solvonis Therapeutics?
The price to earnings ratio of Solvonis Therapeutics is -1.14
What is the cash to sales ratio of Solvonis Therapeutics?
The cash to sales ratio of Solvonis Therapeutics is 5.33
What is the reporting currency for Solvonis Therapeutics?
Solvonis Therapeutics reports financial results in GBP
What is the latest annual turnover for Solvonis Therapeutics?
The latest annual turnover of Solvonis Therapeutics is GBP 587k
What is the latest annual profit for Solvonis Therapeutics?
The latest annual profit of Solvonis Therapeutics is GBP -3.12M
What is the registered address of Solvonis Therapeutics?
The registered address for Solvonis Therapeutics is ECCLESTON YARDS, 25 ECCLESTON PLACE, LONDON, SW1W 9NF
What is the Solvonis Therapeutics website address?
The website address for Solvonis Therapeutics is www.graftpolymer.com
Which industry sector does Solvonis Therapeutics operate in?
Solvonis Therapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIQAiq Limited
4.00p
(33.33%)
37.88k
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
ALKAlkemy Capital Investments Plc
175.00p
(27.27%)
176.27k
KNBKanabo Group Plc
1.00p
(25.00%)
461.04k
TCFTheracryf Plc
1.125p
(25.00%)
6.72M
MET1Metals One Plc
0.275p
(-35.29%)
16.2M
PPSProton Motor Power Systems Plc
0.175p
(-22.22%)
848.7k
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
CGNRConroy Gold & Natural Resources Plc
2.15p
(-18.87%)
739.53k
ONCOncimmune Holdings Plc
10.40p
(-16.47%)
1.19M
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
NTVONativo Resources Plc
0.0018p
(-5.26%)
1.41B
MSMNMosman Oil And Gas Limited
0.041p
(10.81%)
1.22B
TRPTower Resources Plc
0.0295p
(0.00%)
691.76M
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M

Discussion

View Full Feed
Kam8 Kam8 3 hours ago
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 hours ago
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 hours ago
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 hours ago
Gfy is that better?
ENZC
Hicham007 Hicham007 3 hours ago
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 hours ago
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 hours ago
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 hours ago
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 hours ago
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 hours ago
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 hours ago
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 hours ago
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 hours ago
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 hours ago
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 hours ago
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 hours ago
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 hours ago
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 hours ago
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 hours ago
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 hours ago
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 hours ago
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 hours ago
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 hours ago
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 hours ago
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 hours ago
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT

Your Recent History

Delayed Upgrade Clock